Multi-databases were collected to evaluate the different expression, prognostic value, DNA methylation, tumor immune microenvironment, and drug sensitivity of SNRPA1 on ccRCC. This evidence concerns the gene SNRPA1 and nonpapillary renal cell carcinoma.